Form 4: Century Therapeutics CTO Sells Shares for Tax Obligations

Century Therapeutics' Chief Technology and Manufacturing Officer, Gregory Russotti, sold 539 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

Summary

• Gregory Russotti, Chief Technology and Manufacturing Officer of Century Therapeutics, Inc. (IPSC), reported a transaction on September 8, 2025.
• Russotti sold 539 shares of common stock at a price of $0.5 per share.
• The sale was non-discretionary and executed to cover tax withholding obligations associated with the vesting of restricted stock units.
• Following the transaction, Gregory Russotti directly beneficially owns 391,508 shares of common stock.
• Additionally, 92,773 shares are indirectly beneficially owned by the Gregory Russotti 2021 Family Trust.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction is a routine, non-discretionary sale for tax purposes, rather than a discretionary sale indicating a change in confidence or a significant financial event.

Negatives

• Direct beneficial ownership by a key officer decreased by 539 shares.

Future Outlook

No forward-looking statements or guidance were provided regarding the company's future performance or strategic direction.

Management Comments

• The sales reported represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units.
• Such sales were automatic and not at the discretion of the Reporting Person.

Industry Context

This Form 4 filing details an individual insider transaction, which is a routine disclosure for publicly traded companies. It does not provide information on broader industry trends or competitive landscape.

Related Party Transactions

• Gregory Russotti indirectly beneficially owns 92,773 shares through the Gregory Russotti 2021 Family Trust.

Stakeholder Impact

• Shareholders: A minor reduction in direct insider ownership, but for a routine, non-discretionary reason, which typically has minimal impact on investor sentiment.
• Employees (specifically Gregory Russotti): The transaction fulfills tax obligations related to equity compensation, a standard part of executive compensation.

Key Dates

Recommendation

The transaction is a routine, non-discretionary sale of a small number of shares to cover tax obligations related to restricted stock unit vesting. This type of insider transaction does not typically reflect a change in the officer's outlook on the company's prospects or fundamental value, and therefore does not warrant a change in investment recommendation based solely on this filing.

Keywords

Century Therapeutics, IPSC, Form 4, Insider Trading, Stock Sale, Tax Withholding, Restricted Stock Units, Officer Transaction